This dual mechanism is what makes it more effective than single-agonist medications, but it also means the body needs adequate time to adjust to each dose increase
Ghosh A, Chandran K, Kalivendi SV, Joseph J, Antholine WE, Hillard CJ, et al
Reports suggest the peptide may enhance fibroblast migration and proliferation, potentially contributing to faster granulation and re-epithelialization
It should be perfectly transparent with no floaters or cloudiness
Here are some key considerations: Thyroid Disorders: Hypothyroidism can slow down metabolism, making weight loss more difficult
Oral GLP-1s and New Formulations: The December 2025 approval of oral semaglutide (Wegovy pill) and the anticipated approval of orforglipron (Eli Lilly's non-peptide oral GLP-1) in 2026 will expand the patient pool significantly